BIOLIFE SOLUTIONS INC (BLFS) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US09062W2044

Price
38.61 USD
Market cap
1.88 bn USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

BIOLIFE SOLUTIONS INC financials

Fiscal year2025
Revenue96.21 m USD
Gross profit62.12 m USD
Operating income-16.60 m USD
EBIT-4.55 m USD
Net income-4.60 m USD
Diluted EPS – continuing operations-0.10 USD

Full history since 1988, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About BIOLIFE SOLUTIONS INC

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 05.10.2026. Details in the risk notice.